Abingdon Health (Medical)
Abingdon Health is a world leading developer and manufacturer of high-quality rapid lateral flow tests across all industry sectors, including healthcare, animal health and plant health. We take projects from initial concept through to routine and large-scale manufacturing. We also offer flexible solutions for card and strip manufacture through to producing assembled devices and kits. The company has also developed and marketed our own labelled tests. We offer product development, regulatory support, technology transfer, scale-up and manufacturing services for customers for new or existing assays.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Research
- Market Focus:
- Globally (various continents)
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
Who We Are
We are passionate about improving life by making rapid results accessible to all.
About Abingdon Health
We are experts and believe that the field of diagnostics is changing with testing increasingly moving away from traditional lab-based testing alone.
We believe by developing high quality, effective lateral flow rapid tests combined with our manufacturing experience and scale, we can provide the means to accelerate access to rapid testing. This means faster diagnosis and screening in the field, accelerating the ability of decision makers to deploy a more rapid response to results.
Abingdon Health is committed and honest in all that we do. We value the quality and contribution of all, priding ourselves on building long-lasting and trusting partnerships – because by working transparently with customers, partners and colleagues, we are better together. With an exceptional pedigree in developing and manufacturing rapid tests Abingdon Health are expert in responding to our customers varied needs with specific and customisable solutions.
We are a premium global manufacturer and developer of rapid tests and we are the partner of choice for a growing global customer base.
Mission and Vision
Improving life by making rapid results accessible to all
The many benefits of point of care and decentralised testing drives us to innovate and invest in our operations and people. At Abingdon Health we are proud of the critical role we play in providing access to accurate, high quality diagnostic rapid tests. This provides our customers with the means to deliver diagnostic results quickly and aid efficient outcome management. All of which has a positive impact on people’s lives.
Our ambition is to be the leading rapid test business globally and share our mission with all industries.
Our team of multi-disciplinary experts is focused on comprehensive, large-scale, end-to-end contract development and manufacturing.
In 2019 we initiated an expansion strategy to better serve the growing demand for rapid testing, and our ambition is to become the largest rapid test partner in the world. With one of Europe’s largest manufacturing capacities, our forward thinking will allow us to present a compelling solution across all sectors while increasing access to high quality rapid testing.
We are greater than the sum of our parts.
Abingdon Health is committed and honest in all that we do. We value the quality and contribution of all, priding ourselves on building long-lasting and trusting partnerships – by working transparently with customers, partners and colleagues, we are better together.
Quality Standards
Abingdon Health is committed to developing and manufacturing high quality, reliable rapid tests for all partners and industries.
We demonstrate this by working within recognised quality standards.
Abingdon Health operates under an effective Quality Management System for both ISO 13485 and ISO 9001, both of which are managed by our in-house QARA team and regularly audited by an independent organisation.
Our manufacturing facilities operate in accordance with GMP 21CFR820, the requirements of the U.S. Food and Drug Administration (FDA), for the design, development, and manufacture of lateral flow devices, and device readers for in vitro diagnostic medical use.